Patricia Leith, Pharm.D., is Silverback’s executive director of program management and operations. She has over 20 years of experience in program and alliance management in the biotechnology industry, covering all stages of drug development from target selection to commercial life cycle management. Prior to Silverback, Dr. Leith held positions of increasing responsibility at Immunex, ZymoGenetics, and Trubion/Emergent BioSolutions. Before joining the biotechnology industry, she was a clinical oncology pharmacist at the University of Washington Medical Center/Seattle Cancer Care Alliance and a faculty member at the UW School of Pharmacy. She received her Pharm.D. from the University of Washington and completed a residency and fellowship at the University of Washington Medical Center.